These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21176351)

  • 1. [Effect of bortezomib on MAPK signaling pathway of K562/DNR cells].
    Liao AJ; Fu BB; Wang HH; Li YC; Yao K; Zhang R; Yang W; Liu ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1460-3. PubMed ID: 21176351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of different concentrations of bortezomib on the expression of ERK, JNK and P38 in daunorubicin-resistant K562 cells].
    Fu BB; Fan Y; Hao LC; Liao AJ; Liu ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):671-5. PubMed ID: 21729547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of converting K562/DNR cellular drug-resistance by bortezomib.
    Li YC; Wang HH; Liao AJ; Fu BB; Zhang R; Li J; Yang Y; Liu ZG; Yang W
    Eur Rev Med Pharmacol Sci; 2014; 18(10):1465-72. PubMed ID: 24899604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines.
    Zheng B; Zhou R; Gong Y; Yang X; Shan Q
    Int J Lab Hematol; 2012 Jun; 34(3):237-47. PubMed ID: 22145750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
    Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W
    Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Embelin Reverses the Multi-drug Resistance of K562/D to Daunorubicin Independently of P-gp and MDR1 mRNA].
    Jiang HN; Liu ZG; Hu R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1342-1349. PubMed ID: 29070105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferation-inhibiting and multidrug-resistant reversing effect of bortezomib on human HL-60 cells].
    Shang J; Chen ZZ; Wu WB; Wei TN; Chen WM
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):911-6. PubMed ID: 23363746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of proteasome inhibitor bortezomib on a P-gp positive leukemia cell line K562/A02.
    Lü S; Chen Z; Yang J; Chen L; Zhou H; Xu X; Li J; Han F; Wang J
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e123-31. PubMed ID: 19254348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of bortezomib combined with 5-azacytidine on the apoptosis of K562 cells and expression of SHIP mRNA].
    Jia ZQ; Wei YT; Wei YL; Su W; Yu CX; Tao J; Rong HQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1291-4. PubMed ID: 25338575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
    Yin L; Chen BA; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Gao F; Song HH; Bao W; Wu WW; Wang F; Liang YQ; Xia GH; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):79-84. PubMed ID: 20137123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia].
    Zhou RQ; Gong YP; Zheng BH; Yang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):789-92. PubMed ID: 21302442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of mitogen-activated protein kinase in signal transducer and activator of transcription-1 mediated differentiation induced by bortezomib in acute myeloid leukemia cells.
    Zhou X; Fang Y; Jing H; Zhong L; Luo P; Song H; Yang B; He Q
    Mol Carcinog; 2013 Jan; 52(1):18-28. PubMed ID: 22006557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of apoptosis synergistically induced by bortezomib combined with cytarabine in U937 cell line].
    He C; DU X; DU SH; Jia PM; Tong JH; Zhou L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1356-60. PubMed ID: 23257432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and SHIP gene expression in K562 cells].
    Jia ZQ; Wei YT; Li AM; Cheng ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):916-9. PubMed ID: 23998585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells].
    Cai XH; Chen BA; Cheng J; Wang J; Ding JH; Bao W; Zhong YJ; Gao F; Xu WL; Shen HL; Wei HL; Chen J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):24-7. PubMed ID: 21362215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of tetrandrine and 5-bromotetrandrine in reversing multidrug resistance may relate to down-regulation of multidrug resistance associated protein 7 expression.
    Cheng J; Dai JY; Chen BA; Cai XH; Wang S; Gao F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):558-63. PubMed ID: 22739155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro synergistic effect of bortezomib and pirarubicin on proliferation and apoptosis of T cell lymphoma cell line Hut-78 cells].
    Qian ZZ; Wang HQ; Fu K; Ma YL; Hao XS
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):47-51. PubMed ID: 21429402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and XIAP expression in K562 cells].
    Shao M; Sun L; Cui XY; Han XF; Chen SM; Wang F; Zhang H; Ling Z
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):182-6. PubMed ID: 21535957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversal of multidrug resistance in leukemic cell line K562/AO2 by chlordelazine in vitro].
    Chen LJ; Shen SH; Wang HM; Ye X; Jiang SY; Gao F; Li GM
    Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):525-7. PubMed ID: 14746680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide and bortezomib interact synergistically to induce apoptosis in chronic myelogenous leukemia cells resistant to imatinib mesylate through Bcr/Abl‑dependent mechanisms.
    Xu W; Wei W; Yu Q; Wu C; Ye C; Wu Y; Yan H
    Mol Med Rep; 2014 Sep; 10(3):1519-24. PubMed ID: 24939418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.